it should trade up in the lead up to the FDA meeting however everyone will just see it as a semi-binary event again so I'm not expecting any big miracle movements in the lead up.
Post FDA meeting definitely think we will be seeing double digits again and some good buying as we wait for a deal.
For what its worth I'm not concerned regarding the outcome of the FDA meeting. NEU will be submitting all their info/p3 plans to the FDA well in advance and the FDA will give feedback on all this well before the actual meeting takes place (remember the Type B meeting itself only runs for 1 hour!).
So ill say 8-9c in the lead up
12-15c post FDA then tick upward
In reality a p3 approved drug with what they have should be higher than that. If the consolidation and USA life science funds get involved then maybe a higher SP is on the cards... who knows been let down to much on the SP front already so not expecting anything to change. I want to be surprised!
NEU Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)